A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients

AIDS Research and Human Retroviruses

Volumn 14, Issue 7, 1998, Pages 551-560

  Kundu, S K ^a   Engleman, E ^a   Benike, C ^a   Shapero, M H ^a   Dupuis, M ^a   Van Schooten, W C A ^a   Eibl, M ^a   Merigan, T C ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; GAG PROTEIN; GLYCOPROTEIN GP 160; HLA A2 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; LECTIN; PHYTOHEMAGGLUTININ; POL PROTEIN; RECOMBINANT PROTEIN; SYNTHETIC PEPTIDE; TETANUS TOXOID; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC RESTRICTION; ANTIGEN PRESENTATION; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON PRODUCTION; INTRADERMAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032080810     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.551     Document Type: Article

References (44)